# Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke

Study · id `cardio:ct-nct04256473` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04256473](<https://clinicaltrials.gov/study/NCT04256473>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04256473

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT04256473. Randomized; single masking; primary purpose treatment. Start 2019-08-10 (actual); primary completion 2022-03-26 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT04256473, source copy `cardio:ctgov-nct04256473-2023-09-07`, retrieved 2026-10-26)
- Started: 2019-08-10 (actual) (ClinicalTrials.gov record NCT04256473, source copy `cardio:ctgov-nct04256473-2023-09-07`, retrieved 2026-10-26)
- Primary completion: 2022-03-26 (actual) (ClinicalTrials.gov record NCT04256473, source copy `cardio:ctgov-nct04256473-2023-09-07`, retrieved 2026-10-26)
- Completion: 2022-05-26 (actual) (ClinicalTrials.gov record NCT04256473, source copy `cardio:ctgov-nct04256473-2023-09-07`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT04256473, source copy `cardio:ctgov-nct04256473-2023-09-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04256473-2023-09-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
- Acronym: DUMAS
- Condition: Ischemic Stroke
- Intervention (Drug): mutant pro-urokinase
- Intervention (Drug): Alteplase
- Lead sponsor: Erasmus Medical Center
- Lead sponsor class: OTHER
- Collaborator: DUMAS is sponsored by an unrestricted grant from Thrombolytic Science International, paid to the institution.
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Erasmus Medical Center (`cardio:org-erasmus-medical-center`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial (`cardio:pubmed-37213122`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 68393cd1e8ab1381a7797c729fd9f66cc9ec7080bdeeaa026907e7bb1774975f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
